Hepatitis C Clinical Trial
Official title:
A Self-Management Intervention for Veterans With Hepatitis C
The objective of this study is to compare the efficacy of a 6-session hepatitis C self-management workshop to a hepatitis C self-management self-study program. Both interventions are designed to help people with hepatitis C learn to actively self-manage their chronic HCV infection, and ultimately, to improve health outcomes for veterans with HCV who are not receiving Interferon-based treatment. Participants complete a total of four assessments. The fourth assessment, a 12-18 month assessment is an approved addition to the original study design
Background: Chronic hepatitis C (HCV) is a major health concern that disproportionately
affects U.S. veterans. Veterans with HCV experience impaired quality of life as a result of
HCV infection and other co-morbid disorders; namely substance abuse and mental health
problems. Only a small proportion of these patients currently receive and are cured of HCV
with Interferon-based treatments. Treatment recommendations for HCV-infected veterans not
scheduled for Interferon-based treatment include additional evaluations/procedures and
adherence to behavioral/lifestyle guidelines. However, many patients with HCV and commonly
occurring co-morbidities have difficulty following these recommendations without additional
assistance. HCV self-management programs are one option for helping these patients adhere to
treatment recommendations while improving their quality of life. Patient self-management
programs augment traditional information-oriented patient education with problem-solving
skills and cognitive-behavioral techniques that enable patients to manage chronic illness
and their lives as a whole.
Objectives: Our primary objective was to assess the efficacy of a 6-session self-management
workshop designed to improve health outcomes for veterans with HCV who are not receiving
Interferon-based treatment.
Methods: One hundred- thirty seven Veterans with HCV who receive health care at VA San Diego
Healthcare System facilities were randomized to either the HCV Self-Management Workshop
(HCV-SMW) or to the Information intervention study arm. The self-management intervention
includes six 2.5-hour weekly workshop sessions in addition to the basic information provided
to Usual Care. The HCV-SMW was co-led by a health educator and a peer-leader, and has been
adapted from an existing self-management program that has been effective for patients with
other chronic illnesses. The primary outcome for the study is health-related quality of
life. Secondary outcome variables include attendance at recommended health care visits,
self-reported health behaviors related to preventing viral transmission, substance
use/abuse, and patient-provider communication. Data was collected at baseline,
end-of-intervention (6 weeks), at a 12-month and 18-month follow-up visits using self-report
questionnaires. In accordance with HIPAA guidelines, VA medical records and other databases
were accessed to gather data on health care utilization and mortality. Data was analyzed
using repeated-measures analysis of variance, ANCOVA, and linear mixed-model approaches. In
addition, an exploratory cost analysis will be conducted when final analyses are conducted.
Status: The study was completed in 2011. Results have been published and citations are
provided on this website. An additional manuscript including a cost-effectiveness analysis
is in the process of being published.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Recruiting |
NCT04510246 -
Link Hepatitis C Notifications to Treatment in Tasmania
|
N/A | |
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03118674 -
Harvoni Treatment Porphyria Cutanea Tarda
|
Phase 2 | |
Completed |
NCT03109457 -
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
|
||
Completed |
NCT01458054 -
Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults
|
Phase 1 | |
Completed |
NCT03740230 -
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
|
||
Completed |
NCT03426787 -
Helping Empower Liver and Kidney Patients
|
N/A | |
Completed |
NCT03627299 -
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
|
Phase 4 | |
Completed |
NCT00006301 -
Immune Response to Hepatitis C Virus
|
||
Active, not recruiting |
NCT03949764 -
The Kentucky Viral Hepatitis Treatment Study
|
Phase 4 | |
Completed |
NCT03365635 -
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
|
Phase 4 | |
Recruiting |
NCT04405024 -
Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients
|
N/A | |
Completed |
NCT04525690 -
Improving Inpatient Screening for Hepatitis C
|
N/A | |
Completed |
NCT04033887 -
Evaluation Study of RDTs Detecting Antibodies Against HCV
|
||
Withdrawn |
NCT04546802 -
HepATocellular Cancer Hcv Therapy Study
|
Phase 3 | |
Active, not recruiting |
NCT02961426 -
Strategic Transformation of the Market of HCV Treatments
|
Phase 2/Phase 3 | |
Completed |
NCT02869776 -
Integrating HCV and HIV Screening During the Era of HIV Antigen Testing
|
N/A | |
Completed |
NCT02992184 -
PoC-HCV Genedrive Viral Detection Assay Validation Study
|
N/A | |
Completed |
NCT03186313 -
A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection
|
Phase 3 |